News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Ionis announces FDA acceptance of New Drug Application for eplontersen for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN)
Wednesday, March 08, 2023Ionis Pharmaceuticals Nasdaq IONS today announced that the US Food and Drug Administration FDA has accepted for review a New Drug Application NDA for eplontersen an investigational antisense medicine for the treatment of people living with hereditary...
Sun Pharma Completes Acquisition of Concert Pharmaceuticals
Tuesday, March 07, 2023Sun Pharmaceutical Industries Limited today announced the successful completion of its acquisition of Concert Pharmaceuticals Inc a latestage clinical biopharmaceutical company that is developing deuruxolitinib a novel deuterated oral JAK inhibitor f...
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Tuesday, March 07, 2023Evonik and BellaSeno a developer of Dprinted absorbable scaffolds are working together to commercialize innovative Dprinted scaffolds for bone regeneration The bone scaffolds are made with Evoniks Resomer polymers and are used for large and complex b...
PHANES THERAPEUTICS entered into a research collaboration with Xyphos Biosciences, Inc., an Astellas Company
Monday, March 06, 2023Phanes Therapeutics Inc a clinical stage biotech company focused on innovative drug discovery and development in oncology today announced that it has entered into a research collaboration with Xyphos Biosciences Inc an Astellas Company The collaborat...
Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
Friday, March 03, 2023Chugai Pharmaceutical Co Ltd and Biofourmis a global leader in technologyenabled care delivery announced that they have entered into a new partnership agreement for the continued development and realworld use of digital solutions to objectively measu...
MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical
Friday, March 03, 2023MyMD Pharmaceuticals Inc a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases today announced that the US Drug Enforcement Administration DEA...
Framework Solutions Acquires UK-based ONIX Life Sciences
Thursday, March 02, 2023Framework Solutions Frameworks a provider of clinical to commercial solutions to the life sciences industry announced today the acquisition of ONIX Life Sciences ONIX ONIX is a consultancy specializing in regulatory operations services to support lif...
SOPHiA GENETICS and QIAGEN forge partnership to combine strengths in next-generation sequencing
Thursday, March 02, 2023SOPHiA GENETICS a cloudnative software company in the healthcare space today announced a new partnership with QIAGEN NV that will pair QIAseq reagent technology with the SOPHiA DDM platform to enhance tumor analysis through nextgeneration sequencing...
Acquisition of CinCor Pharma complete
Tuesday, February 28, 2023AstraZeneca announced today the successful completion of the acquisition of CinCor Pharma Inc CinCor a USbased clinicalstage biopharmaceutical company focused on developing novel treatments for resistant and uncontrolled hypertension as well as chron...
Evolus Initiates Nuceiva® Launch in Germany and Austria
Tuesday, February 28, 2023Evolus Inc a performance beauty company with a customercentric approach focused on delivering breakthrough products has commenced the commercial launch of Nuceiva botulinum toxin type A in Germany and Austria and is now available for direct order and...
